E Cannabis Stock Sector Was Down Last Week, But Remains +28.7% YTD

munKNEE.com tracks the performance of four (4) cannabis and cannabis-related pot stock categories. Below is a comparison of how each sub-category performed during the first week of June and YTD, and in total.

  1. The American Pure-Play Multi-State Operators Pot Stock Index of 17 constituents tracks the performance of those multi-state marijuana companies that derive 100% of their revenue from the sector, trade for at least US$1/share and have a Market Capitalization in excess of US$100M.
    • It was -0.8% during the first week of June and is now +22.0% YTD with an average Beta of 2.69 and an average Market Capitalization of US$227M.
    • Its constituents are: Curaleaf (CURLF), Green Thumb (GTBIF), Trulieve (TRSSF), Verano (VRNOF), Cresco (CRLBF), TerrAscend (TRSSF), Columbia (CCHWF), Harvest Health (HRVSF), Ascend (AAHW), Planet 13 (PLNHF), Ayr (AYRWF), Jushi (JUSHF), 4 Front (FFNTF), Charlotte's Web (CWBHF), Gage (GAGE), Vireo (VREOF) and Acreage (ACRDF & ACRHF).
      • no major news to report
  2. The Canadian Pure-Play Licensed Producers Pot Stock Index of 6 constituents tracks the performance of those Canadian producers that derive 100% of their revenue from the marijuana sector, trade for at least US$1/share and have a Market Capitalization of at least US$100M.
    • It was -1.7% during the first week of June and is now but is +32.8% YTD with an average Beta of 2.11 and an average Market Capitalization of US$3.6B.
    • Its constituents are: Canopy (CGC), Tilray (TLRY), Cronos (CRON), Aurora (ACB), Organigram (OGI) and Hexo (HEXO).
      • Canopy Growth was -7.0 last week with the announcement that it had ended a joint venture with More Life led by Canadian musician Aubrey Drake Graham (Drake) and also as a result of unfavorable Q4 financial results.
  3. The Ancillary Pot Stock Index of 8 constituents tracks the performance of companies that provide goods and services to cannabis operators and have a Market Capitalization of at least US$100M.
    • It was -8.5% during the first 3 weeks of June and is now +30.9% YTD with an average Beta of 2.2 and an average Market Capitalization of US$3.2B.
    • Its constituents are: Scotts Miracle-Gro (SMG), Innovative REIT (IIPR), Grow Generation (GRWG), Hydrofarm (HYFM), Turning Point (TPB), Village Farms (VFF), Forian (FORA) and AFC Gamma (AFCG).
  4. The Cannabis-Centric BioPharma Stock Index of 7 constituents tracks the stock performance of those clinical-stage biopharmaceutical companies involved in the exclusive development of drugs using CBD and THC and have a Market Capitalization of US$50M or more.
    • It was -5.8% during the first week of June and is now +7.2% YTD with an average Beta of 2.9 and an average Market Capitalization of US$109M.
    • Its constituents are: Corbus (CRBP), Zynerba (ZYNE), MGC (MGCLF), Revive (RVVTF), Zelira (ZLDAF), Tetra Bio (TBPMF) and Enveric (ENVB).
      • Corbus announced licensing deals for two new monoclonal antibodies that further strengthens and diversifies its immunology pipeline for inflammatory, fibrotic, and metabolic diseases, and cancer.
1 2
View single page >> |

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.